Efficacy of two formulations of afoxolaner (NexGard ® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe

A multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard ® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under fi...

Source: Parasites and Vectors - September 10, 2018 Category: Microbiology Authors: Wilfried Lebon, Massimo Beccati, Patrick Bourdeau, Thomas Brement, Vincent Bruet, Agnieszka Cekiera, Odile Crosaz, C éline Darmon, Jacques Guillot, Marion Mosca, Didier Pin, Jaroslaw Popiel, Dorota Pomorska Handwerker, Diane Larsen, Eric Tielemans, Fréd Tags: Research Source Type: research